CJC-1295 Therapy
What is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been modified to have a longer half-life than natural GHRH. Often combined with DAC (Drug Affinity Complex) for extended activity, it is frequently paired with Ipamorelin for synergistic growth hormone release. CJC-1295 stimulates consistent, elevated GH levels without the spikes associated with direct HGH injection.
Benefits & Uses
Sustained increase in growth hormone and IGF-1 levels, improved body composition, enhanced recovery from exercise, better sleep quality, increased collagen production for skin and joint health, synergistic effects when combined with Ipamorelin.
Potential Side Effects
Injection site reactions, water retention, numbness or tingling, headache. May cause transient flushing or lightheadedness after injection. Should be used under medical supervision.
Find CJC-1295 Providers Near You
Browse 103 providers offering CJC-1295 therapy in our directory.
Browse ProvidersFrequently Asked Questions
Sustained increase in growth hormone and IGF-1 levels, improved body composition, enhanced recovery from exercise, better sleep quality, increased collagen production for skin and joint health, synergistic effects when combined with Ipamorelin.
CJC-1295 therapy typically costs between $120 and $350 per month, though prices vary by provider, location, and dosage.
CJC-1295 has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Injection site reactions, water retention, numbness or tingling, headache. May cause transient flushing or lightheadedness after injection. Should be used under medical supervision.
PeptideProbe lists 103 providers offering CJC-1295 therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.